Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy

PHASE3RecruitingINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

November 10, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 31, 2028

Conditions
Esophageal Neoplasms
Interventions
DIETARY_SUPPLEMENT

Preoperative immunonutrition

Preoperative immunonutrition includes an omega-3 fatty-acid enriched enteral nutritional emulsion given by oral intake, nasogastric feeding tube or jejunostomy 600ml per day, lasting for the whole period of neoadjuvant chemoradiation. Meanwhile, oral intake is encouraged to reach 25-30kcal/kg through regular food.

Trial Locations (6)

200011

RECRUITING

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

200025

RECRUITING

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

200030

RECRUITING

Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University, Shanghai

200032

RECRUITING

Zhongshan Hospital Affiliated to Fudan University, Shanghai

310022

RECRUITING

Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou

315048

RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

All Listed Sponsors
collaborator

Shanghai Chest Hospital

OTHER

collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

collaborator

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

collaborator

Zhejiang Cancer Hospital

OTHER

lead

Hecheng Li M.D., Ph.D

OTHER

NCT04513418 - Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy | Biotech Hunter | Biotech Hunter